Targeted medicine for ALK-mutated NSCLC

The rapidly changing landscape of NSCLC treatment has drastically improved outcomes for patients. In this interview, Yvonne Summers, BSc, MB ChB, MSc, PhD, FRCP of The Christie NHS Foundation Trust, M... Author: VJOncology Added: 02/01/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts